{"entity":{"id":"viatris","kind":"company","name":"Viatris","aka":["Mylan","Mylan Inc.","Mylan Pharmaceuticals Inc.","Mylan N.V.","Upjohn"],"tldr":"Viatris is the generics and biosimilars group formed in 2020 from Mylan and Pfizer's Upjohn; in cancer care it supplies generic chemotherapies and biosimilar trastuzumab and pegfilgrastim, and Mylan's phase 3 biosimilar trials sit under its name.","summary":"Viatris was created in November 2020 by the merger of Mylan with Upjohn, Pfizer's off-patent medicines business, and is headquartered in Pittsburgh. Its oncology footprint is generic injectable chemotherapies and biosimilars developed with Biocon, including trastuzumab (Ogivri) and pegfilgrastim (Fulphila), whose comparative phase 3 trials were run by Mylan. ClinicalTrials.gov lists Mylan as lead sponsor of those trials, which OnCo attributes to Viatris.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.viatris.com"},{"label":"ClinicalTrials.gov: trials led by Mylan","url":"https://clinicaltrials.gov/search?lead=Mylan"},{"label":"Wikidata","url":"https://www.wikidata.org/wiki/Q101983981"}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":[],"technologies":["g-csf-growth-factors"],"targets":[],"drugs":["trastuzumab-biosimilars","pegfilgrastim"],"companies":["biocon-biologics"],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial","biosimilar"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Pittsburgh, PA","country":"US","companyType":"pharma","website":"https://www.viatris.com","founded":2020,"stage":"public","investors":[],"funding":[]},"route":"/companies/viatris/","neighbours":{"technology":[{"id":"g-csf-growth-factors","kind":"technology","name":"Growth factors: G-CSF and febrile neutropenia prevention","route":"/technologies/g-csf-growth-factors/"}],"drug":[{"id":"pegfilgrastim","kind":"drug","name":"Pegfilgrastim","route":"/drugs/pegfilgrastim/"},{"id":"trastuzumab-biosimilars","kind":"drug","name":"Trastuzumab biosimilars","route":"/drugs/trastuzumab-biosimilars/"}],"company":[{"id":"biocon-biologics","kind":"company","name":"Biocon Biologics","route":"/companies/biocon-biologics/"}],"term":[{"id":"biosimilar","kind":"term","name":"Biosimilar","route":"/terms/biosimilar/"},{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}]}}